Search

Search Results

• 

  Occult axial involvement in patients with psoriatic arthritis mutilans: a case report

  F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano

  88-91

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1146

  2262

  PDF: 1034

• PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett^1|2, Joseph F Merola³, Iain B Mcinnes⁴, Kenneth B Gordon⁵, Richard B Warren⁶, Patrick Healy⁷, Jérémy Lambert⁸, Heather Edens⁹, Barbara Ink¹⁰, Paola Volpe¹¹, Laure Gossec¹² | ¹Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; ²Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; ³Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; ⁴College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; ⁵Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; ⁶Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; ⁷UCB Morrisville, USA; ⁸UCB Colombes, France; ⁹UCB Smyrna, USA; ¹⁰UCB Slough, United Kingdom; ¹¹UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; ¹²Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2295

  38
• 

  Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis

  F.M. Perrotta, G. Guerra, A. De Socio, S. Scriffignano, E. Lubrano

  1-8

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.976

  2866

  PDF: 1570

• Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

  M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1781

  2280

  PDF: 1025

• PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano¹, Davide Gaspare Patti¹, Valentina Boni¹, Stefano Di Murro¹, Cesare Gavotti¹, Roberta Masnata¹, Giulia Calabrese², Gerlando Natalello², Giusy Peluso², Augusta Ortolan^1|2, Enrico De Lorenzis^1|2, Maria Antonietta D'Agostino^1|2. | ¹Università Cattolica del Sacro Cuore, Roma, Italy; ²Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2009

  162

• Long-term survival of methotrexate in psoriatic arthritis

  M. Ricci, G. De Marco, F. Desiati, D. Mazzocchi, L. Rotunno, N. Battafarano, A. Marchesoni

  125-131

  https://doi.org/10.4081/reumatismo.2009.125

  1465

  PDF: 987
• 

  Psoriatic spondyloarthritis and Sjögren syndrome: a casual association?

  V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe

  170-172

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1287

  1434

  PDF: 807

• Metabolic syndrome in inflammatory rheumatic diseases

  D. Malesci, G. Valentini, G. La Montagna

  169-176

  https://doi.org/10.4081/reumatismo.2006.169

  1949

  PDF: 3987

• Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist

  M.A. Cimmino

  239-241

  https://doi.org/10.4081/reumatismo.2008.239

  1168

  PDF: 755
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  2168

  PDF: 546
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1049

  3727

  PDF: 2053

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  https://doi.org/10.4081/reumatismo.2002.344

  1242

  PDF: 1737

• PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs? Laura Scagnellato¹, Giacomo Cozzi¹, Mariagrazia Lorenzin¹, Mariangela Salvato¹, Alessandro Giollo¹, Bernd Raffeiner¹, Antonia Calligaro¹, Teresa Del Ross¹, Sara Bindoli¹, Margherita Zen¹, Paolo Sfriso¹, Andrea Doria¹, Roberta Ramonda¹. | ¹UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2003

  173

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  https://doi.org/10.4081/reumatismo.2007.66

  1899

  PDF: 1160

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  https://doi.org/10.4081/reumatismo.2009.132

  2152

  PDF: 1213

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  176

• Disease disclosure in the workplace in people living with rheumatic diseases: an exploratory study

  S.M.T. Ostuzzi, E.N. Aiello, F. Ingegnoli, C. Pistarini, B. Poletti, V. Silani, E. Fiabane

  01-10-2024

  https://doi.org/10.4081/reumatismo.2024.1689

  1388

  PDF: 283

• PO:10:141 | A Case Study: Navigating the VEXAS Syndrome Mimickers Erika Montabone¹, Richard Borrelli¹, Nicolò Rashidy¹, Fabiana Giannoccaro², Giuseppe Guida², Federico Itri³, Renato Carignola⁴, Simone Negrini¹, Stefania Nicola¹, Luca Lo Sardo¹, Iuliana Badiu¹, Federica Corradi¹, Ambra Bonvicino⁵, Maurizio Balbi⁶, Luisa Brussino¹ | ¹SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino Torino, Italy; ²SSD Asma grave, malattie rare del polmone e fisiopatologia respiratoria, AOU San Luigi Gonzaga Orbassano, Italy; ³SCDU Medicina Interna ad indirizzo Ematologico, AOU San Luigi Gonzaga Orbassano, Italy; ⁴SCDU Medicina Interna, Scleroderma Unit, AOU San Luigi Gonzaga Orbassano, Italy; ⁵SCDU Dermatologia, Città della Salute e della Scienza di Torino Torino, Italy; ⁶SCDU Radiodiagnostica, AOU San Luigi Gonzaga, Dipartimento di Oncologia Orbassano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2309

  54

• Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

  G. Lapadula

  22-29

  https://doi.org/10.4081/reumatismo.2005.4s.22

  937

  PDF: 1172

• PO:02:023 | Monocentric analysis of systemic glucocorticoids in PsA: the art of balancing prescriptive appropriateness and risk factor management Chiara Crotti^{1 2}, Gilberto Cincinelli¹, Giorgia Trignani¹³, Luca Ingrao¹³, Miriam Perino¹³, Roberto Caporali¹³ | ¹Dipartimento di Reumatologia e Scienze Mediche - UOC Clinica Reumatologica, ASST Pini-CTO, Milano; ²Dipartimento di Reumatologia e Scienze Mediche - UOC Osteoporosi e Malattie Metaboliche dell Osso - ASST Pini-CTO, Milano; ³Dipartimento di Scienze Cliniche e di Comunità - Università degli Studi di Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2125

  182

• PO:05:071 | Impact of age at onset on Spondyloarthritis clinical profile and quality of life: a monocentric cohort analysis Federico Fattorini¹, Marco Di Battista¹, Lorenzo Esti¹, Cosimo Cigolini², Andrea Delle Sedie², Marta Mosca^1|2, Linda Carli¹ | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; ²Rheumatology Unit, AOUP, Pisa, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2297

  36

• PO:02:028 | Dal Pain Catastrophizing al Distress Psicologico Multidimensionale: esplorando la complessità dell’Artrite Psoriasica Difficult- to-Treat Francesca Saracino¹, Damiano Currado^1|2, Francesco De Vincenzo³, Francesca Trunfio¹, Annalisa Marino¹, Lyubomyra Kun¹, Erika Corberi¹, Ludovica Lamberti¹, Leonardo Frascà¹, Onorina Berardicurti^1|2, Marta Gatti¹, Marta Vomero^1|2, Roberto Giacomelli^1|2, Luca Navarini^1|2 | ¹Reumatologia e Immunologia Clinica, Dipartimento di Medicina, Università Campus Bio-Medico di Roma, Facoltà di Medicina Roma, Italy; ²Sezione Clinica e di Ricerca di Reumatologia e Immunologia Clinica, Fondazione Policlinico Campus Bio-Medico Roma, Italy; ³Dipartimento di Scienze Umane, Università Europea di Roma Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2287

  18

• PO:02:025 | Real-World Comparative Effectiveness of Upadacitinib in Psoriatic Arthritis: Evaluation of Switching to Upadacitinib Versus Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors After First-Line Tumor Necrosis Factor Inhibitors Valentina Carlini¹, Philip Mease², William Tillett³, Xiaolan Ye⁴, Christopher Saffore⁴, Molly Edwards⁵, Isabel Truman⁵, Sophie Barlow⁵, Jayne Stigler⁴, Bhumik Parikh⁴, Daniel Aletaha⁶ | ¹Abbvie srl Roma, Italy; ²University of Washington School of Medicine Seattle, United States Minor Outlying Islands; ³Department of Rheumatology, Royal National Hospital for Rheumatic Diseases Bath, United Kingdom; ⁴Abbvie Inc. North Chicago, United States Minor Outlying Islands; ⁵Adelphi Real World Bollington, United Kingdom; ⁶Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2286

  26

• Role for familiarity and genetic features in the therapeutic response of psoriatic arthritis

  E. Taccari, A. Spadaro, M.L. Sorgi, V. Riccieri, B. Mora

  162-168

  https://doi.org/10.4081/reumatismo.2004.162

  2754

  PDF: 19218

• Ultrasound assessment of Achilles enthesitis: a dedicated training program

  G. Smerilli, E. Cipolletta, G.M. Destro Castaniti, G. Pieroni, G. Sartini, A. Cenci, A. Di Matteo, M. Di Carlo, G. Guggino, W. Grassi, E. Filippucci

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1717

  1181

  PDF: 296

  SUPPLEMENTARY MATERIAL: 102

• THE HISTOPATHOLOGY OF PSORIASIS

  G. De Rosa, C. Mignogna

  46-48

  https://doi.org/10.4081/reumatismo.2007.1s.46

  4812

  PDF: 7835

• Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis

  C. Salvarani, I. Olivieri, F. Cantini, A. Marchesoni, L. Punzi, R. Scarpa, M. Matucci Cerinic

  133-138

  https://doi.org/10.4081/reumatismo.2004.133

  1606

  PDF: 970